Skip to content
lifestyle.ebusinessplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Femasys Inc.
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
November 16, 2026
Femasys Appoints John Moorhead to Board of Directors
October 30, 2026
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
October 21, 2026
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
October 16, 2026
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
October 13, 2026
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
September 15, 2026
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
September 9, 2026
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
August 26, 2026
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
August 20, 2026
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
August 17, 2026
1
2
Next Page
→